Bafna Pharmaceuticals Limited (BOM:532989)

Market Cap	5.74B +133.8%
Revenue (ttm)	1.43B -3.1%
Net Income	77.86M -5.8%
EPS	3.24 -7.0%
Shares Out	n/a
PE Ratio	73.66
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,565
Open	237.40
Previous Close	242.20
Day's Range	237.40 - 247.00
52-Week Range	91.20 - 296.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 406
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532989

Financial Performance

In fiscal year 2026, Bafna Pharmaceuticals's revenue was 1.51 billion, an increase of 3.26% compared to the previous year's 1.46 billion. Earnings were 111.00 million, an increase of 167.30%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error